Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1571635
PUBLISHER: Grand View Research | PRODUCT CODE: 1571635
Injectable Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Therapeutic Use, By End-use, By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Injectable Drug Delivery Devices Market Growth & Trends:
The global injectable drug delivery devices market size is anticipated to reach USD 823.29 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.7% from 2024 to 2030. The increase in the number of chronic diseases like diabetes and cancer has fueled the need for injectable drug delivery. Unlike other traditional forms of drug delivery, injectables allow maximum bioavailability of the pharmaceutical drug as it bypasses the first-pass metabolism. With substantial growth in technological advancements, the devices being manufactured and marketed are built so as to cater to the specific needs of the patients.
With the advent of self-injection devices, injectable drugs can be self-administered without the need for medical assistance. A large number of technology-oriented developments have taken place in the biologics market, which further increases the applicability of these injectable devices in the challenging disease areas. Self-injection devices have allowed patients suffering from diabetes to manage insulin levels with auto-injectors, pen-injectors, and needle-free injectors; thus, the homecare segment has been a large grosser in the end-user application.
The major restraints in this market are injuries and infections caused by needles, ambiguities related to regulatory reimbursements, sterility of the injectable drugs, and the preference of other drug delivery systems that possess less toxicity and are easy to administer. Despite these restraints, the market potential for injectable drug delivery products is tremendous with the majority of the key players opting to injectables over other forms of delivery. The injectable drug delivery industry, based on product type is segmented into two sub-types namely self-injection devices and conventional injection devices. Further, on the basis of therapeutic use, the injectable drug delivery industry is segmented into autoimmune disorders, hormonal disorders, oncology, and others.
The injectable drug delivery industry by end-user application is categorized into hospitals, home care settings, and others including research establishments, diagnostics, and clinical laboratories.
Injectable Drug Delivery Devices Market Report Highlights:
- Oncology is anticipated to witness the fastest CAGR of 9.3% over the forecast period. This is due to the growing incidence of cancer globally and the evolution of targeted therapies.
- Hospitals dominated the market with 53.2% share in 2023. Hospitals are increasingly adopting advanced injectable devices due to their ability to provide rapid therapeutic effects, which is crucial in emergency care and critical situations.
- North America injectable drug delivery devices market dominated with 40.5% market share in 2023. North America has a significant population with chronic diseases such as diabetes, cancer, and autoimmune disorders.
Product Code: 978-1-68048-GVR-8
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Injectable Drug Delivery Devices Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Injectable Drug Delivery Devices Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter's Analysis
Chapter 4. Injectable Drug Delivery Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Injectable Drug Delivery Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Devices
- 4.3.1. Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Self-injection Devices
- 4.3.2.1. Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Conventional Devices
- 4.3.3.1. Conventional Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Formulations
- 4.4.1. Formulations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Conventional Drug Delivery
- 4.4.2.1. Conventional Drug Delivery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Novel Drug Delivery
- 4.4.3.1. Novel Drug Delivery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4. Others
- 4.4.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Injectable Drug Delivery Devices Market: Therapeutic Use Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Injectable Drug Delivery Devices Market: Therapeutic Use Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. Autoimmune Disorders
- 5.3.1. Autoimmune Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Hormonal Disorders
- 5.4.1. Hormonal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Oncology
- 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Others
- 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Injectable Drug Delivery Devices Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Injectable Drug Delivery Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
- 6.3. Hospitals
- 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Homecare Settings
- 6.4.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Others
- 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Injectable Drug Delivery Devices Market: Regional Estimates & Trend Analysis
- 7.1. Injectable Drug Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
- 7.2. North America
- 7.2.1. North America Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. U.S. Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Canada Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Mexico Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
- 7.3.2.1. UK Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Germany Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
- 7.3.4.1. France Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Italy Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Spain Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1. Denmark Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Sweden Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Norway Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
- 7.4.2.1. China Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Japan Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
- 7.4.4.1. India Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
- 7.4.5.1. South Korea Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Australia
- 7.4.6.1. Australia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1. Thailand Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Brazil Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
- 7.5.3.1. Argentina Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. South Africa Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Saudi Arabia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. UAE Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Kuwait Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Heat Map Analysis
- 8.4. Company Profiles
- 8.4.1. Baxter
- 8.4.1.1. Participant's Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Schott AG
- 8.4.2.1. Participant's Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. BD
- 8.4.3.1. Participant's Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Eli Lilly and Company
- 8.4.4.1. Participant's Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Terumo Corporation
- 8.4.5.1. Participant's Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Elcam Medical
- 8.4.6.1. Participant's Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Unilife Corporation
- 8.4.7.1. Participant's Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Ypsomed AG
- 8.4.8.1. Participant's Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Gerresheimer AG
- 8.4.9.1. Participant's Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.10. Sanofi
- 8.4.10.1. Participant's Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Recent Developments/ Strategic Initiatives
- 8.4.1. Baxter
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.